11.52000 EUR
0.27
2.40%
Last update Dec 15, 11:27 AM CET
Main market
Day range
11.52000
11.52000
Previous close
11.25
Open
11.52000
Access this stock data via API
Subscribe
Astellas Pharma Inc.
11.52
0.27
2.40%

Financials

Income statement

Fundamentals currency is JPY
Fiscal date 2025 2024 2023 2022
Total reported revenue 10.5B 9.3B 1.5T 1.3T
Cost of revenue 1.9B 1.7B 288.4B 253.0B
Gross profit 8.6B 7.6B 1.2T 1.0T
Operating expense
Research & development 1.8B 1.7B 276.1B 246.0B
Selling general and admin 4.6B 4.3B 630.3B 548.8B
Other operating expenses 1.3B 968.5M 157.5B 104.3B
Operating income 220.9M 109.3M 131.6B 131.0B
Non operating interest income
Income 43.2M 66.1M 8.1B 6.1B
Expense 97.0M 69.3M 8.8B 4.9B
Other income expense
Pretax income 171.5M 144.1M 132.4B 156.9B
Tax provision -107.1M 45.7M 33.6B 32.8B
Net income 278.6M 98.4M 98.7B 124.1B
Basic EPS 9.5 54.2 67.1
Diluted EPS 9.5 54.1 67.1
Basic average shares 9.8M 10.3M 1.8B 292.1B
Diluted average shares 9.8M 10.3M 1.8B 292.1B
EBITDA 1.4B 1.1B 246.7B 217.3B
Net income from continuing op. 171.5M 144.1M 132.4B 156.9B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 21 minutes

12:38
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).